Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
World’s First Chemo Drone Delivery Announced on NHS Birthday
NHS cancer patients will be the first in the world to benefit from chemotherapy delivered […]
Digital Revolution to Bust COVID Backlogs and Deliver More Tailored Care for Patients
People across the country will benefit from faster, more personalised healthcare, following a digital revolution […]
Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]
New Phase III Data Show Novartis Tislelizumab Significantly Extended Median Overall Survival by More Than 6 Months in First-line Advanced Esophageal Cancer in Combination With Chemotherapy
Today Novartis announced results from the Phase III RATIONALE 306 trial showing tislelizumab plus chemotherapy […]
GSK Completes Acquisition of Sierra Oncology
GSK plc (LSE/NYSE: GSK) today announced it has completed the acquisition of Sierra Oncology, Inc. […]
Revolution in Care of Leukaemia as New Treatment Drug Approved for Cancer Patients
The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence […]
Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
The PanDIA-1 Study, for Early Detection of Pancreatic Cancer in Newly Onset Type 2 Diabetics, Moves Into Next Phase
Immunovia today announced the PanDIA-1 study for the early detection of pancreatic cancer in newly […]
Roche Launches New BenchMark ULTRA PLUS System for Cancer Diagnostics Enabling Timely, Targeted Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the BenchMark ULTRA PLUS system, its […]
Cepheid and BioGX Announce Collaboration to Develop Monkeypox PCR Test for the GeneXpert® System
Cepheid and BioGX today announced a collaboration between the two companies to deliver a PCR […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more